BackAlaunos Therapeutics Overview

Alaunos Therapeutics Other Current Assets

Latest other current assets for TCRT: $540K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$542000.00
36.76% YoYΔ $-315000.00 vs prior year quarter

Peer average / median

Loading

Alaunos Therapeutics Other Current Assets History

Loading

Alaunos Therapeutics vs. peers: Other Current Assets Comparison

Loading

Alaunos Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alaunos Therapeutics (TCRT) FAQ

Alaunos Therapeutics (TCRT) currently reports a other current assets of $540K as of June 2026. That compares with $860K in the prior-year period — down 36.8% year over year. Use the charts on this page to explore Alaunos Therapeutics's other current assets history and peer comparisons.

Alaunos Therapeutics's other current assets decreased from $860K to $540K — a 36.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alaunos Therapeutics reported $540K in other current assets as of June 2026. That compares with $860K in the prior-year period — down 36.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $540K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alaunos Therapeutics, and consider following TCRT for alerts when major investors trade the stock.

Alaunos Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $540K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TCRT with unrelated industries.